首站-论文投稿智能助手
典型文献
Risk factors and outcomes for patients with pancreatic cancer undergoing surgical exploration without resection due to metastatic disease:A national cohort study
文献摘要:
Background:Unresectable disease is sometimes diagnosed during surgery in patients with pancreatic ductal adenocarcinoma(PDAC).This study aimed to identify preoperative risk factors for metastatic dis-ease diagnosed at surgical exploration and to investigate and compare survival in resected and non-resected patients.Methods:Patients were identified from the Swedish National Pancreatic and Periampullary Cancer Reg-istry 2010-2018.Predictors of metastatic disease were evaluated with a multivariable logistic regression model,and survival was evaluated with Kaplan-Meier estimates and log-rank tests.Results:In total,1938 patients with PDAC were scheduled for surgery.An unresectable situation was diagnosed intraoperatively in 399 patients(20.6%),including 234(12.1%)with metastasized disease.In-dependent risk factors for metastasis were involuntary weight loss(OR = 1.72;95%CI:1.27-2.33)and elevated carbohydrate antigen 19-9(CA19-9)(35-599 U/mL,OR = 1.79,95%CI:1.11-2.89;>600 U/mL,OR = 3.24,95%CI:2.04-5.17).Overall survival was lower among patients with metastasized disease than that among patients with a resectable tumor(P<0.001).Conclusions:Involuntary weight loss and an elevation of CA19-9 are preoperative risk factors for diag-nosing metastasized disease during surgical exploration.
文献关键词:
作者姓名:
Emil Sahlstr?m;Paulina Bereza-Carlson;Johan Nilsson;Bobby Tingstedt;Bodil Andersson
作者机构:
Department of Clinical Sciences Lund,Surgery,Lund University,Sweden;Department of Surgery,Central Hospital Kristianstad,Sweden;Department of Translational Medicine,Cardiothoracic surgery and bioinformatics,Lund University,Sweden;Department of Thoracic and vascular surgery,Sk?ne University hospital,Lund,Sweden;Department of Surgery,Sk?ne University Hospital,Lund,Sweden
引用格式:
[1]Emil Sahlstr?m;Paulina Bereza-Carlson;Johan Nilsson;Bobby Tingstedt;Bodil Andersson-.Risk factors and outcomes for patients with pancreatic cancer undergoing surgical exploration without resection due to metastatic disease:A national cohort study)[J].国际肝胆胰疾病杂志(英文版),2022(03):279-284
A类:
Unresectable,Periampullary,metastasized,Involuntary,nosing
B类:
Risk,factors,outcomes,patients,pancreatic,cancer,undergoing,surgical,exploration,without,resection,due,metastatic,disease,national,cohort,study,Background,sometimes,diagnosed,during,surgery,ductal,adenocarcinoma,PDAC,This,aimed,identify,preoperative,risk,investigate,compare,survival,resected,Methods,Patients,were,identified,from,Swedish,National,Pancreatic,Cancer,Reg,istry,Predictors,evaluated,multivariable,logistic,regression,model,was,Kaplan,Meier,estimates,rank,tests,Results,total,scheduled,An,unresectable,situation,intraoperatively,including,dependent,metastasis,involuntary,weight,loss,elevated,carbohydrate,antigen,CA19,Overall,lower,among,than,that,tumor,Conclusions,elevation
AB值:
0.504122
相似文献
Comparison of outcomes between immediate implant- based and autologous reconstruction: 15-year, single-center experience in a propensity score-matched Chinese cohort
Shanshan He;Bowen Ding;Gang Li;Yubei Huang;Chunyong Han;Jingyan Sun;Qingfeng Huang;Jing Liu;Zhuming Yin;Shu Wang;Jian Yin-Department of Breast Reconstruction,Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Sino-Russian Joint Research Center for Oncoplastic Breast Surgery,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,University College London,London WC1N 1AX,UK;Department of Cancer Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
Haploidentical hematopoietic stem cell transplantation may improve long-term survival for children with high-risk T-cell acute lymphoblastic leukemia in first complete remission
Zhang Yongzhan;Bai Lu;Cheng Yifei;Lu Aidong;Wang Yu;Wu Jun;Zhang Xiaohui;Zuo Yingxi;Xu Lanping;Jia Yueping;Huang Xiaojun;Zhang Leping-Department of Pediatrics, Peking University People’s Hospital, Peking University, Beijing 100044, China;Department of Hematology, Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China;Department of Pediatrics, Peking University Shougang Hospital, Peking University, Beijing 100144, China;Department of Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China
Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program
Wu Zheng;Tan Fengwei;Yang Zhuoyu;Wang Fei;Cao Wei;Qin Chao;Dong Xuesi;Zheng Yadi;Luo Zilin;Zhao Liang;Yu Yiwen;Xu Yongjie;Ren Jiansong;Shi Jufang;Chen Hongda;Li Jiang;Tang Wei;Shen Sipeng;Wu Ning;Chen Wanqing;Li Ni;He Jie-Office of Cancer Screening, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Key Laboratory of Cancer Data Science, Chinese Academy of Medical Sciences, Beijing 100021, China;Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;PET-CT Center, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Department of Diagnostic Radiology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Hepatopancreatoduodenectomy for advanced biliary malignancies
Wu Xiangsong;Li Maolan;Wu Wenguang;Wang Xu’an;Li Huaifeng;Bao Runfa;Shu Yijun;Shen Jun;Gu Jun;Wang Xuefeng;Gong Wei;Peng Shuyou;Liu Yingbin-Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai 200092, China;Shanghai Research Center of Biliary Tract Disease, Shanghai 200092, China;Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;State Key Laboratory of Oncogenes and Related Genes, Shanghai 200092, China;Department of General Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejing 310009, China
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Changlong Li;Zhen Guan;Yi Zhao;Tingting Sun;Zhongwu Li;Weihu Wang;Zhexuan Li;Lin Wang;Aiwen Wu-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Pathology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiation Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Cancer Epidemiology,Peking University Cancer Hospital&Institute,Beijing 100142,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。